(11) Patent Number | 035323 |
Date of Registration in the Register of Eurasian Patents | 2020.05.27 |
(21) Application Number | 201791134 |
(22) Filling Date | 2013.01.12 |
(51) IPC |
A61K 38/37 (2006.01)
C07K 14/755 (2006.01)
C12N 15/63 (2006.01) |
(43)(13) Application Publication Date(s), Kind Code(s) | A1 2018.02.28 Issue No 02  title, specification
|
(45)(13) Patent Publication Date(s), Kind Code(s) | B1 2020.05.28 Issue No 05 title, specification  SEQL
|
(31) Number(s) assigned to Priority Application(s) | 61/586,099
61/586,654
61/667,901
61/734,954
|
(32) Date(s) of filing of Priority Application(s) | 2012.01.12
2012.01.13
2012.07.03
2012.12.07
|
(33) Priority Application Office | US
US
US
US
|
(62) Number and date of filing of initial application, from which the present application has been divided | 201491186; 2013.01.12 |
(71) Applicant(s) | БИОВЕРАТИВ ТЕРАПЬЮТИКС ИНК. (US) |
(72) Inventor(s) | Чабра Экта Сет, Лю Туняо, Питерс Роберт, Цзян Хайянь (US) |
(73) Patent Owner(s) | БИОВЕРАТИВ ТЕРАПЬЮТИКС ИНК. (US) |
(54) Title | ПОЛИПЕПТИДЫ ХИМЕРНОГО ФАКТОРА VIII И ИХ ПРИМЕНЕНИЕ |
